HIV-positive gay and bi men are more likely to be acutely (very recently) infected with hepatitis C if they have casual sex partners.

The severity of liver fibrosis is associated with cognitive dysfunction independent of hepatitis C or HIV status.

A massive scale-up of hep C treatment in injection drug users would be required to lower the rate of new infections among the population.

A recent study says HIV-positive people who contract hepatitis C have an increased risk of kidney disease and osteoporosis, even if cured.

People with hepatitis C very rarely have a viral relapse after acheiving a sustained virologic response 12 weeks after finishing treatment.

Drinking at least three cups of coffee a day is linked with a lowered risk of death among people coinfected with HIV and hepatitis C.

Sovaldi (sofosbuvir) and ravidasvir, with or without ribavirin, cured almost all people with genotype 4 of hepatitis C in a large trial.

Among HIV-positive men who have sex with men, crystal meth use is associated with a much higher risk of contracting hepatitis C sexually.

Sovaldi (sofosbuvir)–based hepatitis C regimens boast high cure rates in real-world practice among those coinfected with HIV.

A intensive care coordination program showed a high level of success in getting a group of urban people with hep C cured of the virus.